ASCO 2020   

Questions discussed in this category

Does the absence of an OS benefit in the AG221-AML-005 presented at ASCO 2020 deter you from this strategy?

Does the SYSUCC-001 trial presented at ASCO 2020 change your practice?

Given data presented at ASCO 2020?

Papers discussed in this category

N. Engl. J. Med.,

J. Clin. Oncol., 2019 Dec 05

N. Engl. J. Med., 2020 May 29

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-12-01

N. Engl. J. Med.,